UBP
TENX icon

Union Bancaire Privee’s Tenax Therapeutics TENX Stock Holding History

Union Bancaire Privee’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11 Hold
1
– – ﹤0.01% 486
2026
Q1 		$11 Hold
1
– – ﹤0.01% 483
2025
Q4 		$9 Hold
1
– – ﹤0.01% 498
2025
Q3 		$6 Hold
1
– – ﹤0.01% 482
2025
Q2 		$5 Hold
1
– – ﹤0.01% 496
2025
Q1 		$6 Hold
1
– – ﹤0.01% 507
2024
Q4 		$6 Buy
+1
New +$5 ﹤0.01% 572

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Union Bancaire Privee's TENX Position: Q2 2026 in Review

Union Bancaire Privee held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 1 share worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Union Bancaire Privee first reported a position in TENX in Q4 2024 and has held it in 7 quarters since. 23 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Union Bancaire Privee held 1 share of Tenax Therapeutics worth $11 as of Q2 2026.
  • Union Bancaire Privee left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #486 holding.
  • Union Bancaire Privee first reported a position in Tenax Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.